Article Versions Notes

Ghilencea L-N, Bejan G-C, Zamfirescu M-B, Stănescu AMA, Matei L-L, Manea L-M, Kilic ID, Bălănescu S-M, Popescu A-C, Myerson SG. B-Type Natriuretic Peptide at Admission Is a Predictor of All-Cause Mortality at One Year after the First Acute Episode of New-Onset Heart Failure with Preserved Ejection Fraction. Journal of Personalized Medicine. 2022; 12(6):890. https://doi.org/10.3390/jpm12060890

Ghilencea, Liviu-Nicolae, Gabriel-Cristian Bejan, Marilena-Brîndusa Zamfirescu, Ana Maria Alexandra Stănescu, Lavinia-Lucia Matei, Laura-Maria Manea, Ismail Dogu Kilic, Serban-Mihai Bălănescu, Andreea-Catarina Popescu, and Saul Gareth Myerson. 2022. "B-Type Natriuretic Peptide at Admission Is a Predictor of All-Cause Mortality at One Year after the First Acute Episode of New-Onset Heart Failure with Preserved Ejection Fraction" Journal of Personalized Medicine 12, no. 6: 890. https://doi.org/10.3390/jpm12060890

Ghilencea, L.-N., Bejan, G.-C., Zamfirescu, M.-B., Stănescu, A. M. A., Matei, L.-L., Manea, L.-M., Kilic, I. D., Bălănescu, S.-M., Popescu, A.-C., & Myerson, S. G. (2022). B-Type Natriuretic Peptide at Admission Is a Predictor of All-Cause Mortality at One Year after the First Acute Episode of New-Onset Heart Failure with Preserved Ejection Fraction. Journal of Personalized Medicine, 12(6), 890. https://doi.org/10.3390/jpm12060890